| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $67.6M | -14.6% |
| R&D Expense | $131.5M | -19.6% |
| SG&A Expense | $57.9M | +9.4% |
| Operating Income | -$121.7M | +11.3% |
| Pre-tax Income | -$117.8M | +10.1% |
| Income Tax | -$1.7M | -161.8% |
| Net Income | -$116.0M | +13.3% |
| EPS (Basic) | -$5.48 | +14.1% |
| EPS (Diluted) | -$5.48 |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.2M | -56.4% |
| Accounts Receivable | $6.6M | -22.8% |
| Current Assets | $299.9M | -29.1% |
| Total Assets | $376.7M | -18.5% |
| Current Liabilities | $57.5M | -8.4% |
| Total Liabilities | $247.8M | +0.9% |
| Stockholders' Equity | $128.8M | -40.6% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.8M | +23.6% |
| Capital Expenditures | $17.9M | +98.1% |
| Investing Cash Flow | $58.2M | +208.7% |
| Financing Cash Flow | -$27.6M | -113.9% |
| Free Cash Flow | -$96.7M | +13.8% |
| +14.1% |